These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22074295)

  • 21. Obesity, psychiatric status, and psychiatric medications.
    Berkowitz RI; Fabricatore AN
    Psychiatr Clin North Am; 2011 Dec; 34(4):747-64. PubMed ID: 22098801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weight change with atypical antipsychotics in the treatment of schizophrenia.
    Haddad P
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse events in children and adolescents treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2008 Jun; 23(4):283-90. PubMed ID: 18302312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resting energy expenditure is lower than predicted in people taking atypical antipsychotic medication.
    Sharpe JK; Byrne NM; Stedman TJ; Hills AP
    J Am Diet Assoc; 2005 Apr; 105(4):612-5. PubMed ID: 15800566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Cobaugh DJ; Erdman AR; Booze LL; Scharman EJ; Christianson G; Manoguerra AS; Caravati EM; Chyka PA; Woolf AD; Nelson LS; Troutman WG
    Clin Toxicol (Phila); 2007 Dec; 45(8):918-42. PubMed ID: 18163235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of atypical antipsychotic medications in adolescent psychiatric inpatients: a comparison with inpatients who did not receive antipsychotic medications during their stay.
    Pogge DL; Young K; Insalaco B; Harvey PD
    Int J Clin Pract; 2007 Jun; 61(6):896-902. PubMed ID: 17504351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The implications of weight changes with antipsychotic treatment.
    Sussman N
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weight gain associated with taking psychotropic medication: an integrative review.
    McCloughen A; Foster K
    Int J Ment Health Nurs; 2011 Jun; 20(3):202-22. PubMed ID: 21492360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
    Olfson M; Blanco C; Liu L; Moreno C; Laje G
    Arch Gen Psychiatry; 2006 Jun; 63(6):679-85. PubMed ID: 16754841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of weight management interventions for people with serious mental illness who receive treatment with atypical antipsychotic medications. A literature review.
    Lowe T; Lubos E
    J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):857-63. PubMed ID: 19012677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient attitudes toward weight gain with medications.
    Sansone RA; Sansone LA; Gaither GA; Morris JL
    Gen Hosp Psychiatry; 2004; 26(6):487-9. PubMed ID: 15567217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic Side Effects in Patients Using Atypical Antipsychotic Medications During Hospitalization.
    Dikeç G; Arabaci LB; Uzunoglu GB; Mizrak SD
    J Psychosoc Nurs Ment Health Serv; 2018 Apr; 56(4):28-37. PubMed ID: 29328360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial.
    Alvarez-Jiménez M; Martínez-García O; Pérez-Iglesias R; Ramírez ML; Vázquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2010 Jan; 116(1):16-9. PubMed ID: 19896336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding women veterans' experiences with and management of weight gain from medications for serious mental illness: A qualitative study.
    Kreyenbuhl J; Lucksted A; Despeaux K; Sykes VM
    Psychiatr Rehabil J; 2019 Sep; 42(3):238-245. PubMed ID: 30920258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Meaningful Day Group approach to weight gain from antipsychotic medication.
    O'Melia J; Shaw P; Dickinson C
    J Psychiatr Ment Health Nurs; 2004 Feb; 11(1):112-6. PubMed ID: 14723647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of the initiation of psychotherapeutic medicine use.
    Trinkoff AM; Anthony JC; Muñoz A
    Am J Public Health; 1990 Jan; 80(1):61-5. PubMed ID: 1967156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.